Objective
The authors examined a low-capacitance waveform typical of a low-energy/high peak current commercial application (100µF capacitance, < 200 Joules) and a high-capacitance waveform typical of a high-energy/lower peak current commercial application (200 µF capacitance, > 200 Joules). The objective was to determine which design results in greater defibrillation success, better resuscitation and survival outcome, and lower myocardial dysfunction.
Methodology
Ventricular fibrillation (VF) was induced in anesthetized 40-45 kg pigs. After 7 minutes in VF, resuscitation was attempted using a sequence of up to three defibrillation shocks followed by 1 minute of CPR, and repeated if necessary for up to 15 minutes. Animals were randomized to one of four groups: Significantly more shocks and more CPR were required for • the pigs resuscitated with the high-capacitance therapy.
Significantly higher post-resuscitation myocardial dysfunction • was observed with the high-capacitance therapy.
The authors observe, "Higher peak current is associated with improved survival, whereas higher energy and higher average current are associated with increased post-resuscitation myocardial dysfunction…Post-resuscitation myocardial dysfunction has been associated with early death after initial successful resuscitation."
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Conclusions
The authors conclude, "With respect to patient outcome, these results suggest that peak current is a more appropriate measure of defibrillation dose than either energy or average current and that toxicity may be minimized by simultaneously reducing both of the latter…survival was maximized and myocardial dysfunction minimized using a waveform that simultaneously delivered higher peak current while minimizing energy and average current." Philips Healthcare reserves the right to make changes in specifications and/ or to discontinue any product at any time without notice or obligation and will not be liable for any consequences resulting from the use of this publication. 
Philips Commentary
The Philips waveform maximizes peak current for shock efficacy while minimizing energy to limit toxicity and dysfunction for an already compromised heart. The study demonstrates that this is a beneficial combination. It means Philips can deliver its most potent therapy from the very first shock. There is no need to hold back for fear of compromising an already fragile heart.
Philips' use of low capacitance, similar to that seen in the low capacitance arm of this study, enables Philips to use less (toxic) energy to deliver more (therapeutic) current. At every energy level, Philips delivers higher peak current, demonstrating true efficiency.
By contrast, the high capacitance therapy requires a lot more energy to achieve the same resuscitation benefits, bringing along toxic side effects. Manufacturers employing high capacitance start with their weakest shock. If it fails, they escalate energy to drive higher current once, maybe twice, with long CPR intervals between each shock. It may take several minutes to reach the shock strength required for that patient. 
